Cargando…

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome

Accumulating evidence shows that microbes with their theater of activity residing within the human intestinal tract (i.e., the gut microbiome) influence host metabolism. Some of the strongest results come from recent fecal microbial transplant (FMT) studies that relate changes in intestinal microbio...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Vossen, Eduard W. J., Bastos, Diogo, Stols-Gonçalves, Daniela, de Goffau, Marcus C., Davids, Mark, Pereira, Joao P. B., Li Yim, Andrew Y. F., Henneman, Peter, Netea, Mihai G., de Vos, Willem M., de Jonge, Wouter, Groen, Albert K., Nieuwdorp, Max, Levin, Evgeni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583152/ https://www.ncbi.nlm.nih.gov/pubmed/34747338 http://dx.doi.org/10.1080/19490976.2021.1993513

Ejemplares similares

Recent insights into the role of microbiome in the pathogenesis of obesity
por: van der Vossen, Eduard W. J., et al.
Publicado: (2022)

Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters
por: Bresser, Lucas R. F., et al.
Publicado: (2022)

Gut microbiome transitions across generations in different ethnicities in an urban setting—the HELIUS study
por: van der Vossen, Eduard W. J., et al.
Publicado: (2023)

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2019)

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2023)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
por: Smits, Loek P., et al.
Publicado: (2018)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric Bypass
por: Wijdeveld, Madelief, et al.
Publicado: (2023)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel Disease
por: Joustra, Vincent, et al.
Publicado: (2022)

Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance
por: Hartstra, Annick V., et al.
Publicado: (2020)

Does disease start in the mouth, the gut or both?
por: Prodan, Andrei, et al.
Publicado: (2019)

Differential DNA methylation in familial hypercholesterolemia
por: Reeskamp, Laurens F., et al.
Publicado: (2020)

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
por: de Groot, Pieter F., et al.
Publicado: (2017)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Fecale microbiota transplantatie, meer dan een behandeling voor Clostridium difficile?
por: Nieuwdorp, Max
Publicado: (2020)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal microbiota transplantation and fiber supplementation, better together?
por: Hanssen, Nordin M.J., et al.
Publicado: (2021)

Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study
por: Singh, Ramandeep, et al.
Publicado: (2018)

Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
por: Liu, Moyan, et al.
Publicado: (2022)

Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing
por: Prodan, Andrei, et al.
Publicado: (2020)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites
por: van Baar, Annieke C G, et al.
Publicado: (2018)

Fecal microbiota transplantation in metabolic syndrome: History, present and future
por: de Groot, P. F., et al.
Publicado: (2017)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area
por: Balvers, Manon, et al.
Publicado: (2021)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without
por: de Goffau, Marcus C., et al.
Publicado: (2013)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Concordance between culture, Molecular Culture and Illumina 16S rRNA gene amplicon sequencing of bone and ulcer bed biopsies in people with diabetic foot osteomyelitis
por: Gramberg, Meryl Cinzía Tila Tamara, et al.
Publicado: (2023)

Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
por: van Beurden, Yvette H., et al.
Publicado: (2017)

Drivers and determinants of strain dynamics following fecal microbiota transplantation
por: Schmidt, Thomas S. B., et al.
Publicado: (2022)

Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn’s Disease Patients
por: Joustra, Vincent W., et al.
Publicado: (2022)

Species- and strain-level assessment using rrn long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
por: Benítez-Páez, Alfonso, et al.
Publicado: (2022)

Statistical evaluation of diet-microbe associations
por: Zhang, Xiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8tlbi05qf68q27ac8g4o9h1gt0